SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Other Accumulated Expenses (2021 - 2025)

SeaStar Medical Holding's (ICU) quarterly Other Accumulated Expenses came in at $241000.0 in Q2 2025, up 148.45% YoY from $97000.0 in Q2 2024, and down 23.97% on a QoQ basis from $317000.0 in Q1 2025.

SeaStar Medical Holding (ICU) Other Accumulated Expenses (2021 - 2025) Analysis & Trends

SeaStar Medical Holding (ICU) has 5 years of Other Accumulated Expenses data on file, last reported at $241000.0 in Q2 2025.

  • Quarterly Other Accumulated Expenses rose 148.45% year-over-year to $241000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $241000.0 (up 148.45% YoY) and the FY2024 annual result came in at $383000.0, up 335.23% from the prior year.
  • Other Accumulated Expenses eased to $241000.0 in Q2 2025, from $317000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $383000.0 in Q4 2024 to a low of $17000.0 in Q1 2024.
  • A 5-year average of $155166.7 and a median of $109500.0 in 2022 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses plunged 76.06% — and 2025, when it jumped 1764.71%.
  • Tracing ICU's Other Accumulated Expenses over 5 years: stood at $29000.0 in 2021, then soared by 320.69% to $122000.0 in 2022, then slipped by 27.87% to $88000.0 in 2023, then surged by 335.23% to $383000.0 in 2024, then tumbled by 37.08% to $241000.0 in 2025.
  • The last three Other Accumulated Expenses figures came in at $241000.0 (Q2 2025), $317000.0 (Q1 2025), and $383000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00

Historic Data

Download Data
DateValue
Jun 30, 2025 241,000.00
Mar 31, 2025 317,000.00
Dec 31, 2024 383,000.00
Sep 30, 2024 281,000.00
Jun 30, 2024 97,000.00
Mar 31, 2024 17,000.00
Dec 31, 2023 88,000.00
Sep 30, 2023 159,000.00
Jun 30, 2023 57,000.00
Mar 31, 2023 71,000.00
Dec 31, 2022 122,000.00
Dec 31, 2021 29,000.00